top of page

ΕΠΙΣΤΗΜΟΝΙΚΟ ΕΡΓΟ
Δημοσιεύσεις

Δημοσιεύσεις σε διεθνή περιοδικά

β2 -MICROGLOBULIN IN HODGKIN’S LYMPHOMA: PROGNOSTIC SIGNIFICANCE IN PATIENTS TREATED WITH ABVD OR EQUIVALENT REGIMENS.
Vassilakopoulos TP, Nadali G, Angelopoulou MK, Dimopoulou MN,  Siakantaris MP, Kontopidou FN, Karkantaris C, Kokoris SI, Dimitriadou EM, Calpadakis C, Sarantopoulos A, Galani Z, Sachanas S, Kyrtsonis MC, Tsaftaridis P, Variami E, Panayiotidis P, Pizzolo G, Sarris AH, Pangalis GA

Journal of BUON. 2005

Δείκτηςαπήχησης: 0,76

 

IMMUNOTHERAPEUTIC AND IMMUNOREGULATORY DRUGS IN HEMATOLOGIC MALIGNANCIES.
Pangalis GA, Kyrtsonis M-C, Vassilakopoulos TP, Dimopoulou MN, Siakantaris MP, Emmanouilides C, Doufexis D, Sahanas S, Kontopidou FN, Kalpadakis C, Angelopoulou MK, Dimitriadou EM, Kokoris SI, Panayiotidis P. 

Current Topics in Medical Chemistry. 2006

Αριθμός βιβλιογραφικών αναφορών: 9

Δείκτης απήχησης: 3,7
 

PROGNOSTIC VALUE OF SERUM FREE LIGHT CHAIN RATIO (FLCR) AT DIAGNOSIS IN MULTIPLE MYELOMA (MM).
Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, Sachanas S, Tzenou T, Papadogiannis A, Galanis Z, Kalpadakis C, Dimou M, Kyriakou E, Angelopoulou MK, Dimopoulou MN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Panayiotidis P, Pangalis GA.
British Journal of Haematology. 2007

Αριθμός βιβλιογραφικών αναφορών: 55

Δείκτης απήχησης: 4,9
 

BIOLOGIC AND CLINICAL OVERLAP OF IGM-SECRETING LYMPHOMAS; FOCUS ON "WALDENSTROM'S MACROGLOBULINEMIA (WM).
Pangalis GA, Tzenou T, Kalpadakis C, Vassilakopoulos TP, Dimitriadou EM, Sachanas S, Petrikkos L, Angelopoulou MK, Siakantaris MP, Dimopoulou MN, Kokoris SI, Tsaftaridis P, Panayiotidis P, Kyrtsonis M-C.
Haematologica. 2007

Δείκτης απήχησης: 5,9
 

NORMALIZATION OF THE SERUM ANGIOPOIETIN-1 TO ANGIOPOIETIN-2 RATIO FEFLECTS RESPONSE IN REFRACTORY/RESISTANT MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB.
Anargyrou K, Terpos E, Vassilakopoulos TP, Pouli A, Sachanas S, Tzenou T, Masouridis S, Christoulas D, Angelopoulou MK, Dimitriadou EM, Kalpadakis C, Tsionos K, Panayiotidis P, Dimopoulos MA, Pangalis GA, Kyrtsonis M-C. 

Haematologica. 2008

Αριθμός βιβλιογραφικών αναφορών: 14

Δείκτης απήχησης: 5,9
 

OUTCOME AND TOXICITY IN RELAPSED HAIRY CELL LEUKEMIA PATIENTS TREATED WITH RITUXIMAB.

Angelopoulou MK, Pangalis GA, Sachanas S, Kokoris SI, Anargyrou K, Galani Z, Kalpadakis C, Vassilakopoulos TP.
Leukemia Lymphoma. 2008; 49: 1817-1820.

Αριθμός βιβλιογραφικών αναφορών: 8

Δείκτης απήχησης: 2,3
 

NON-GASTRIC MALT LYMPHOMAS A SINGLE CENTER EXPERIENCE ON 76 PATIENTS.

Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Kyrtsonis M-C, Siakantaris MP, Kontopidou FN, Korkolopoulou P, Bobotsis P, Sahanas S,Tzenou T, Anagnostou D, Dimitriadou E, Yiakoumis X, Patsouris E/ Roussou P, Panayiotidis P, Papadaki E, Angelopoulou MK.
Leukemia Lymphoma. 2008

Αριθμός βιβλιογραφικών αναφορών: 13

Δείκτης απήχησης: 2,3
 

MUTATION ANALYSIS OF IGVH GENES IN SPLENIC MARGINAL ZONE LYMPHOMAS CORRELATION WITH CLINICAL CHARACTERISTICS AND OUTCOME.
Kalpadakis C, Pangalis G.A., Dimitriadou E., Angelopoulou Μ. Κ., Siakantaris M.P., Kyrtsonis M.C., Ximeris M., Tzenou T., Kontopidou F., Sachanas S., Yiakoumis X., Papadaki E.A., Panayiotidis P., Vassilakopoulos T.
Anticancer Research. 2009

Αριθμός βιβλιογραφικών αναφορών: 2

Δείκτης απήχησης: 1,7
 

EARLY STAGE GASTRIC MALT LYMPHOMA. IS IT A TRUE LOCALIZED DISEASE?
Siakantaris MP, Pangalis GA, Dimitriadou E, Kontopidou FN, Vassilakopoulos TP, Kalpadakis C,Sachanas S, Yiakoumis X, Korkolopoulou, P, Kyrtsoni MC, Bobotsis C, Androulakis A, Patsouris E, Panayiotidis P, Angelopoulou MK.
Oncologist. 2009

Αριθμόςβιβλιογραφικώναναφορών: 2

Δείκτηςαπήχησης: 4,1
 

COMBINATION OF RITUXIMAB WITH CHLORAMBUCIL AS FIRST LINE TREATMENT IN PATIENTS WITH MANTLE CELL LYMPHOMA: A HIGHLY EFFECTIVE REGIMEN.
Sachanas S, Pangalis GA, Vassilakopoulos TP, Korkolopoulou P, Kontopidou FN, Athanasoulia M, Yiakoumis X, Kalpadakis C, Georgiou G, Masouridis S, Moschogiannis M, Tsirkinidis P, Pappis V, Kokoris SI, Siakantaris MP, Panayiotidis P, Angelopoulou MK.

LeukemiaLymphoma. 2011

Αριθμός βιβλιογραφικών αναφορών: 9

Δείκτηςαπήχησης: 2,3
 

RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE WITH OR WITHOUT RADIOTHERAPY IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: THE EMERGING STANDARD OF CARE.
Vassilakopoulos TP, Pangalis GA, Katsigiannis A, Papageorgiou SG, Constantinou N, Terpos E, Zorbala A, Vrakidou E, Repoussis P, Poziopoulos C, Galani Z, Dimopoulou MN, Kokoris SI, Sachanas S, Kalpadakis C, Dimitriadou EM, Siakantaris MP, Kyrtsonis MC, Dervenoulas J, Dimopoulos MA, Meletis J, Roussou P, Panayiotidis P, Beris P, Angelopoulou MK.

Oncologist. 2012

Αριθμός βιβλιογραφικών αναφορών: 6

Δείκτηςαπήχησης: 4,1
 

TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA WITH RITUXIMAB MONOTHERAPY: PROGRESS REPORT AND COMPARISON WITH SPLENECTOMY.
Kalpadakis C,Pangalis GA, Angelopoulou MK, Sachanas S, Kontopidou FN, Yiakoumis X, Kokoris SI, Dimitriadou EM, Dimopoulou MN, Moschogiannis M, Korkolopoulou P, Kyrtsonis MC, Siakantaris MP, Papadaki T, Tsaftaridis P, Plata E, Papadaki HE, Vassilakopoulos TP.
Oncologist. 2013

Αριθμόςβιβλιογραφικώναναφορών: 2

Δείκτηςαπήχησης: 4,1
 

APOPTOTIC AND PROLIFERATIVE CHARACTERISTICS OF PROLIFERATION CENTERS IN LYMPH NODE SECTIONS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
Sachanas S, Levidou G, Angelopoulou MK, Moschogiannis M, YiakoumisX, Kalpadakis C, Vassilakopoulos TP, Kontopidou F, Tsirkinidis P, Dimitrakopoulou A, Kokoris S, Dimitriadou E, Kyrtsonis MC, Panayiotidis P, Papadaki H, Patsouris E, Korkolopoulou P, Pangalis GA. 

Leukemia Lymphoma 2013 

Δείκτηςαπήχησης: 2,3
 

TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA: SHOULD SPLENECTOMY DE ABANDONED?

Kalpadakis C, Pangalis GA, Vassilakopoulos TP,Sachanas S, Angelopoulou MK.

Leukemia Lymphoma 2014

Δείκτηςαπήχησης: 2,3
 

ANGIOGENESISI IN CHRONIC LYMPHOCYTIC LEUKEMIA

S.Sachanas, M.K.Angelopoulou, P.Korkolopoulou, C.Kalpadakis, P.Tsarkinidis, M.Moschogiannis, X.Giakoumis, A.Dimitrakopoulou, T.P.Vassilakopoulos,   G.A.Pangalis.

Current Angiogenesis 2013 

 

CLONAL B-CELL LYMPHOCYTOSIS EXHIBITING IMMUNOPHENOTYPIC FEATURES CONSISTENT WITH A MARGINAL ZONE ORIGIN: IS THIS A DISTINCT ENTITY? 

A.Xochelli, C.Kalpadakis, A.Gardiner, P.Baliakas, T.P.Vassilakopoulos, S.Mould, Z.Davis, E.Stalika, G.Kanellis, M.K.Angelopoulou, N.Mclever-Brown, R.Ibbotson, S.Sachanas, P.Korkolopoulou, A.Athanasiadou, A.Anagnostopoulos, H.Papadaki, T.Papadaki, K.Stamatopoulos, G.A.Pangalis, D.Oscier.

Blood 2014

Αριθμός βιβλιογραφικών αναφορών: 1 

Δείκτης απήχησης: 9,0

 

VALIDATION OF THE SIMPLIFIED PROGNOSTIC SCORE FOR SPLENIC MARGINAL ZONE LYMPHOMA OF THE SPLENIC MARGINAL ZONE LYMPHOMA STUDY GROUP. 

C.Kalpadakis, G.A.Pangalis, M.K.Angelopoulou, S.Sachanas, F.Kontopidou, M.Moschogiannis, M.Ximeri, P.Tsirkinidis, X.Yiakoumis, H.Papadaki, T.P.Vassilakopoulos, 

Leukemia Lymphoma.2014

Δείκτηςαπήχησης: 2,3
 

IMMUNOHISTOCHEMICAL ANALYSIS OF IL-6, IL-8/CXCR2 AXIS, Tyrp-STAT-3, AND SOCS-3 IN LYMPH NODES FROM PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: CORRELATION BETWEEN MICROVASCULAR CHARACTERISTICS AND PROGNOSTIC SIGNIFICANCE.

Georgia Levidou, Sotirios Sachanas,Gerassimos A. Pangalis, Christina Kalpadakis, Xanthi Yiakoumis, Maria Moschogiannis, Athanasia Sepsa, Eleftheria Lakiotaki, Vassilis Milionis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Pantelis Tsirkinidis, Flora Kontopidou, Styliani Kokoris, Marina Siakantaris, Maria Angelopoulou, Helen Papadaki, Nikolaos Kavantzas, Panayiotis Panayiotidis, Efstratios Patsouris, and Penelope Korkolopoulou.

BioMed Research Internalional.2014 

 

NEW INSIGHTS INTO MONOCLONAL B-CELL LYMPHOCYTOSIS

Christina Kalpadakis, Gerassimos A. Pangalis, Sotirios Sachanas, Theodoros Vassilakopoulos, Stavroula Kyriakaki, Penelope Korkolopoulou, Efstathios Koulieris, Maria Moschogiannis, Xanthi Yiakoumis, Pantelis Tsirkinidis, Marie-Christine Kyrtsonis, Georgia Levidou, Helen A. Papadaki, Panayiotis Panayiotidis, Maria K. Angelopoulou. 

BioMed Research Internalional.2014 

 

THE ROLE OF AKT/m TOR CASCADE IN HAIRY CELL LEUKEMIA: INTERACTION WITH BRAF/ERK SIGNALLING PATHWAY AND PROGNOSTIC SIGNIFICANCE. 

Eleftheria Lakiotaki, Georgia Levidou, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, Gabriella Gainaru, Pagona Flevari, Sotirios Sachanas, Angelica A. Saetta, Athanasia Sepsa, Maria Moschogiannis, Christina Kalpadakis, Vassilios Milionis, Ilenia Chatziandreou, Irene Thymara, Panayiotis Panayiotidis, Maria Dimopoulou, Eleni Plata, Konstantinos Konstantopoulos, Efstratios Patsouris, Maria Angelopoulou, Penelope Korkolopoulou.Sci Rep. 2016

 

SERUM SOLUBLE TACI, A BLyS RECEPTOR, IS A POWERFULL PROGNOSTIC MARKER OF OUTCOME IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). 

Marie-Christine Kyrtsonis, Katerina Sarris, Efstathios Koulieris, Dimitrios Maltezas, Eftychia Nikolaou, Maria K. Angelopoulou, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, Marina Siakantaris, Nora Vyniou, Sotirios Sachanas,Christina Kalpadakis, Petros P. Sfykakis, Gerassimos A. Pangalis, Panayiotis Panayiotidis

BioMed Research Internalional.2014 

 

CLINICAL ASPECTS OF MALT LYMPHOMAS

Christina Kalpadakis, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, Stavroula Kyriakaki, Xanthi Yiakoumis, Sotirios Sachanas, Maria Moschogiannis, Penelope Korkolopoulou, Helen Papadaki, Maria K. Angelopoulou.

Curr Hematol Malig Rep.2014

 

COMPOSITE LYMPHOMAS: A CHALLENGING ENTITY

Sotirios Sachanas, Gerassimos A. Pangalis, Christina Kalpadakis, Xanthi Yiakoumis, Maria Moschogiannis, Marie-Christine Kyrtsonis,Theodoros P. Vassilakopoulos,Pantelis Tsirkinidis, Flora Kontopidou,Styliani Kokoris, Marina Siakantaris, Nora-Athina Viniou, Pinelopi Korkolopoulou, Helen Papadaki, Panayiotis Panayiotidisand Maria Angelopoulou.

Current Cancer Therapy Reviews 2012

 

EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOMA TISSUE (MALT) WITH CONCURRENT EXISTENCE OF HIGH GRADE COMPONENT AT DIAGNOSIS: CLINICOPATHOLOGIC FEATURES AND TREATMENT STRATEGY.

Sotirios Sachanas, Gerassimos A. Pangalis, Christina Kalpadakis, Georgia Levidou, Xanthi Yiakoumis, Maria Moschogiannis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Pantelis Tsirkinidis, Marina Siakantaris, Chariklia Spiliadi, Evangelia Karagianni, Penelope Korkolopoulou, Helen Papadaki, Panayiotis Panayiotidis and Maria Angelopoulou

Leuk Lymphoma. 2015 

 

PET/CT IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RESPONDING TO RITUXIMAB-CHOP: AN ANALYSIS OF 106 PATIENTS REGARDING PROGNOSTIC SIGNIFICANCE AND IMPLICATIONS FOR SUBSEQUENT RADIOTHERAPY.

Vassilakopoulos TP, Pangalis GA, Chatziioannou S, Papageorgiou S, Angelopoulou MK, Galani Z, Kourti G, Prassopoulos V, Leonidopoulou T, Terpos E, Dimopoulou MN, Sachanas S, Kalpadakis C, Konstantinidou P, Boutsis D, Stefanoudaki E, Kyriazopoulou L, Siakantaris MP, Kyrtsonis MC, Variami E, Kotsianidis I, Symeonidis A, Michali E, Katodritou E, Kokkini G, Tsatalas C, Papadaki H, Dimopoulos MA, Sotiropoulos V, Pappa V, Karmiris T, Meletis J, Apostolidis J, Datseris I, Panayiotidis P, Konstantopoulos K, Roussou P, Rondogianni P.

Leukemia. 2015

 

EXUBERANT CORTICAL THYMOCYTE PROLIFERATION MIMICKING T-LYMPHOBLASTIC LYMPHOMA WITHIN RECURRENT LARGE INGUINAL LYMPH NODE MASSES OF LOCALIZED CASTLEMAN DISEASE.

Kansal R, Nathwani BN, Yiakoumis X, Moschogiannis M, Sachanas S, Stefanaki K, Pangalis GA.

Hum Pathol. 2015 

 

GASTRIC INVOLVEMENT IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.

Papageorgiou SG, Sachanas S, Pangalis GA, Tsopra O, Levidou G, Foukas P, Rondogianni P, Sotiropoulos V, Ioannidou HD, Gassiamis A, Iliakis T, Korkolopoulou P, Angelopoulou MK, Pappa V, Konstantopoulos K, Vassilakopoulos TP.

Anticancer Res. 2014 

 

HEPATIC AND RENAL PLASMA CELL LESIONS IN A PATIENT WITH MULTIPLE MYELOMA IN HEMATOLOGICAL REMISSION

Galani Z, Viniou N, Kyrtsonis Mc, Sachanas S, Antoniou T, Dimopoulou Mn, Vassilakopoulos Tp, Korkolopoulou P, Nakopoulou L, Patsouris E, Pangalis Ga.

Anticancer Research.2007

 

ASSESSMENT OF BORTEZOMIB INDUCED PERIPHERAL NEUROPATHY IN MULTIPLE MYELOMA BY THE REDUCED TOTAL NEUROPATHY SCORE.

Zaroulis CK, Chairopoulos K, Sachanas SP, Maltezas D, Tzenou T, Pessach I, Koulieris E, Koutra E, Kilindireas K, Pangalis GA, Kyrtsonis MC.Leukemia Lymphoma. 2014

 

PROGNOSTIC SIGNIFICANCE OF SERUM FREE LIGHT CHAINS IN CHRONIC LYMPHOCYTIC LEUKEMIA.

Sarris K, Maltezas D, Koulieris E, Bartzis V, Tzenou T, Sachanas S, Nikolaou E, Efthymiou A, Bitsani K, Dimou M, Vassilakopoulos TP, Siakantaris M, Angelopoulou MK, Kontopidou F, Tsaftaridis P, Kafasi N, Pangalis GA, Panayiotidis PP, Harding S, Kyrtsonis MC.

Adv Hematol. 2013

 

RE-EVALUATION OF PROGNOSTIC MARKERS INCLUDING STAGING, SERUM FREE LIGHT CHAINS OR THEIR RATIO AND SERUM LACTATE DEHYDROGENASE IN MULTIPLE MYELOMA PATIENTS RECEIVING NOVEL AGENTS.

Maltezas D, Dimopoulos MA, Katodritou I, Repousis P, Pouli A, Terpos E, Panayiotidis P, Delimpasi S, Michalis E, Anargyrou K, Gavriatopoulou M, Stefanoudaki A, Tzenou T, Koulieris E, Sachanas S, Dimou M, Vassilakopoulos TP, Angelopoulou MK, Pangalis GA, Kyrtsonis MC.

Hematol Oncol. 2013 

 

LEUKEMIC TRANSFORMATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AFTER TREATMENT WITH GRANULOCYTE COLONY-STIMULATING FACTOR.

Diamantopoulos PT, Chatzileonida T, Galanopoulos A, Yiakoumis X, Saridaki AM, Angelidis A, Papakostas E, Bazanis E, Sachanas S, Michael M, Pangalis GA, Anagnostopoulos NI, Meletis J, Viniou NA.

Leuk Lymphoma. 2012 

 

NO EVIDENCE OF SPLENIC DISEASE IN PATIENTS WITH SPLENIC MARGINAL ZONE LYMPHOMA UNDERGOING SPLENECTOMY FOR AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MONOTHERAPY WITH RITUXIMAB

Kalpadakis C, Pangalis GA, Sachanas S, Rontogianni D, Korkolopoulou P,Milionis V, Vassilakopoulos TP, Papadaki HA, Angelopoulou MK.

Leuk Lymphoma 2016. 

 

PROGNOSTIC IMPLICATION OF THE ABSOLUTE LYMPHOCYTE TO ABSOLUTE MONOCYTE COUNT RATIO IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA TREATED WITH DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE OR EQUIVALENT REGIMENS.Vassilakopoulos TP, Dimopoulou MN, Angelopoulou MK, Petevi K, Pangalis GA, Moschogiannis M, Dimou M, Boutsikas G, Kanellopoulos A, Gainaru G, Plata E, Flevari P, Koutsi K, Papageorgiou L, Telonis V, Tsaftaridis P, Sachanas S, Yiakoumis X, Tsirkinidis P, Viniou NA, Siakantaris MP, Variami E, Kyrtsonis MC, Meletis J, Panayiotidis P, Konstantopoulos K.Oncologist 2016.

 

MUCORMYCOSIS PRESENTING WITH DENTAL PAIN AND PALATAL ULCER IN A PATIENT WITH CHRONIC MYELOMONOCYTIC LEUKEMIA. REPORT OF A CASE AND LITERATURE REVIEW. 

Ourania Nicolatou-Galitis,  Sotirios Sachanas; Maria Drogari-Apiranthitou; Maria Moschogiannis; Dimitra Galiti; Xanthi Yiakoumis; Demetra Rontogianni; Ioannis Yiotakis; George Petrikkos; Gerassimos Pangalis.

Journal of Cancer Metastasis and Treatment(JCMT) 2015

 

OSTEONECROSIS OF THE JAW IN A PATIENT WITH ACUTE MYELOID LEUKEMIA, WHO RECEIVED AZACITIDINE Ourania Nicolatou-Galitis , Dimitra Galiti, Maria Moschogianni, Sotirios Sachanas, Beatrice J. Edwards, Cesar A. Migliorati, Gerassimos Pangalis.Journal of Cancer Metastasis and Treatment(JCMT) 2016.

POTENTIAL ROLE OF AKT/MTOR SIGNALLING PROTEINS IN HAIRY CELL LEUKAEMIA: ASSOCIATION WITH BRAF/ERK ACTIVATION AND CLINICAL OUTCOME.

Lakiotaki E, Levidou G, Angelopoulou MK, Adamopoulos C, Pangalis G, Rassidakis G, Vassilakopoulos T, Gainaru G, Flevari P, Sachanas S, Saetta AA, Sepsa A, Moschogiannis M, Kalpadakis C, Tsesmetzis N, Milionis V, Chatziandreou I, Thymara I, Panayiotidis P, Dimopoulou M, Plata E, Konstantopoulos K, Patsouris E, Piperi C, Korkolopoulou P.

Sci Rep. 2016

 

NO EVIDENCE OF SPLENIC DISEASE IN PATIENTS WITH SPLENIC MARGINAL ZONE LYMPHOMA UNDERGOING SPLENECTOMY FOR AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MONOTHERAPY WITH RITUXIMAB.

Kalpadakis C, Pangalis GA, Sachanas S, Rontogianni D, Korkolopoulou P, Milionis V, Vassilakopoulos TP, Papadaki HA, Angelopoulou MK.Leuk Lymphoma. 2016

 

MALAKOPLAKIA OF THE URINARY BLADDER IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA UNDER IBRUTINIB THERAPY: A CASE REPORT.

Sachanas S, Pangalis GA, Karouzakis P, Koulieris E, Moschogiannis M, Kalpadakis C, Yiakoumis X, Rontogianni D.Anticancer Res. 2016

 

DETECTION OF L265P MYD-88 MUTATION IN A SERIES OF CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ).

Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Roumelioti M, Sachanas S, Korkolopoulou P, Koulieris E, Moschogiannis M, Yiakoumis X, Tsirkinidis P, Pontikoglou C, Rondoyianni D, Papadaki HA, Panayiotidis P, Angelopoulou MK.Hematol Oncol. 2016

 

HODGKIN LYMPHOMA TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA UNDER IBRUTINIB THERAPY: CHANCE ASSOCIATION OR THERAPY-RELATED?

Sachanas S, Pangalis GA, Moschogiannis M, Yiakoumis X, Koulieris E, Tsirkinidis P, Kalpadakis C, Rontogianni D.Anticancer Res. 2017

 

THE SIGNIFICANCE OF PET/CT IN THE INITIAL STAGING OF HODGKIN LYMPHOMA: EXPERIENCE OUTSIDE CLINICAL TRIALS.

Angelopoulou MK, Mosa E, Pangalis GA, Rondogianni P, Chatziioannou S, Prassopoulos V, Moschogianni M, Tsirkinidis P, Asimakopoulos JV, Konstantinou I, Tsourouflis G, Sachanas S, Yiakoumis X, Boutsikas G, Arapaki M, Gainaru G, Kyrtsonis MC, Siakantaris MP, Datseris I, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP.Anticancer Res. 2017 

 

RITUXIMAB MONOTHERAPY IN SPLENIC MARGINAL ZONE LYMPHOMA: PROLONGED RESPONSES AND POTENTIAL BENEFIT FROM MAINTENANCE. Kalpadakis C, Pangalis GA, Sachanas S, Tsirkinidis P, Kontopidou FN, Moschogiannis M, Yiakoumis X, Koulieris E, Dimopoulou MN, Kokkoris SI, Kyrtsonis MC, Siakantaris MP, Tsourouflis G, Korkolopoulou P, Rontogianni D, Tsaftaridis P, Plata E, Papadaki HA, Panagiotidis P, Angelopoulou MK, Vassilakopoulos TP.

Blood. 2018 
 

SMALL LYMPHOCYTIC LYMPHOMA: ANALYSIS OF TWO COHORTS INCLUDING PATIENTS IN CLINICAL TRIALS OF THE GERMAN CHRONIC LYMPHOCYTIC LEUKEMIA STUDY GROUP (GCLLSG) OR IN "REAL-LIFE" OUTSIDE OF CLINICAL TRIALS.

Sachanas S, Pangalis GA, Fink AM, Bahlo J, Fischer K, Levidou G, Kyrtsonis MC, Bartzi V, Vassilakopoulos TP, Kalpadakis C, Koulieris E, Moschogiannis M, Yiakoumis X, Tsirkinidis P, Angelopoulou MK, Eichhorst B, Hallek M. Anticancer Res. 2019 May;39(5):2591-2598

Ωρες Ιατρείου

Δευτέρα & Τετάρτη: 17:00 - 21:00

Πέμπτη & Παρασκευή: 18:00 - 20:00
Σάβατο-Κυριακή: ΜΟΝΟ έκτακτα 

Χαϊμαντά 22, 15234, Χαλάνδρι, Αθήνα

 

Τηλ.: 6974390445 2106850202

Email: ssachanas@gmail.com

Για ερωτήσεις, ραντεβού 
ή οποιαδήποτε επικοινωνία

Ευχαριστώ για την επικοινωνία!

© 2025 by Σαχανάς Σωτήριος.
All Rights Reserved.

bottom of page